PD-L1 expression correlates with tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy in breast cancer

Programmed death 1 ligand 1 (PD-L1) is an immune regulatory molecule that limits antitumor immune activity. Targeting of PD-L1 and other immune checkpoint proteins has shown therapeutic activity in various tumor types. The expression of PD-L1 and its correlation with response to neoadjuvant chemothe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Immunol Res
Hoofdauteurs: Wimberly, Hallie, Brown, Jason R, Schalper, Kurt, Haack, Herbert, Silver, Matthew R., Nixon, Christian, Bossuyt, Veerle, Pusztai, Lajos, Lannin, Donald R, Rimm, David L
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4390454/
https://ncbi.nlm.nih.gov/pubmed/25527356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0133
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items